fosinopril has been researched along with avapro in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Intengan, HD; Li, JS; Schiffrin, EL; Thibault, G | 1 |
| Ferrari, P; Frey, FJ; Marti, HP; Pfister, M | 1 |
| Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
| Angulo, E; Barquero, A; Grois, J; Pérez Miranda, M; Robles, NR | 1 |
| Azizi, M; Bissery, A; Bura-Rivière, A; Ménard, J | 1 |
| Berthier, C; Ferrari, P; Frey, FJ; Kappeler, A; Lods, N; Marti, HP; Vogt, B | 1 |
| Larouche, I; Pu, Q; Schiffrin, EL | 1 |
| Angulo, E; Barquero, A; Grois, J; Robles, NR | 1 |
| Huang, YL; Sun, YH; Zhang, RY | 1 |
| Gu, Y; Lin, S; Ma, J; Zhang, L | 1 |
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for fosinopril and avapro
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for fosinopril and avapro
| Article | Year |
|---|---|
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
[Comparison of the antihypertensive activity of fosinopril and irbesartan].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2002 |
Dual renin-angiotensin system blockade restores blood pressure-renin dependency in individuals with low renin concentrations.
Topics: Adolescent; Adult; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Drug Therapy, Combination; Fosinopril; Humans; Irbesartan; Male; Natriuresis; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Tetrazoles; Urine | 2003 |
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Case-Control Studies; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Fosinopril; Glomerulonephritis; Humans; Irbesartan; Male; Matrix Metalloproteinases; Middle Aged; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Tetrazoles | 2003 |
Comparative effects of fosinopril and irbesartan on hematopoiesis in essential hypertensives.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Erythrocyte Count; Female; Follow-Up Studies; Fosinopril; Hematopoiesis; Hemoglobins; Humans; Hypertension; Irbesartan; Male; Middle Aged; Tetrazoles; Time Factors | 2004 |
6 other study(ies) available for fosinopril and avapro
| Article | Year |
|---|---|
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Collagen; Elastin; Fosinopril; Hypertension; Integrins; Irbesartan; Male; Mesenteric Arteries; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vascular Resistance | 1999 |
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Creatinine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fosinopril; Humans; Irbesartan; Male; Middle Aged; Potassium; Proteinuria; Receptors, Angiotensin; Tetrazoles; Treatment Outcome | 2002 |
Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Biphenyl Compounds; Blood Pressure; Capillaries; Coronary Circulation; Drug Therapy, Combination; Fosinopril; Hypertension; Irbesartan; Male; Myocytes, Cardiac; Neprilysin; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Thiazepines | 2003 |
[Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Drug Synergism; Fosinopril; Irbesartan; Male; Myocardial Infarction; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Ventricular Remodeling | 2005 |
Effects of blocking the renin-angiotensin system on expression and translocation of protein kinase C isoforms in the kidney of diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Biphenyl Compounds; Blotting, Western; Cell Membrane; Cytosol; Diabetes Mellitus, Experimental; Drug Combinations; Fosinopril; Immunohistochemistry; Irbesartan; Kidney; Kidney Cortex; Male; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Tissue Distribution | 2006 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |